Paul Tudor Jones’s Alignment Healthcare ALHC Stock Holding History

Paul Tudor Jones’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Buy	+9,600	New	+$184K	﹤0.01%	3260

Other funds holding ALHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's ALHC Position: Q2 2026 in Review

Paul Tudor Jones sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 212,489 shares — an estimated $4.08M sold.

Paul Tudor Jones first reported a position in ALHC in Q1 2021 and held it in 14 quarters. The position peaked at $15.9M in Q2 2025. 321 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

Paul Tudor Jones reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 212,489 Alignment Healthcare shares in Q2 2026, an estimated $4.08M.
Paul Tudor Jones first reported a position in Alignment Healthcare in Q1 2021 and held it in 14 quarters.
Paul Tudor Jones's Alignment Healthcare position peaked at $15.9M in Q2 2025.
321 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.